Fate Therapeutics Inc. buy Wedbush
Start price
27.10.25
/
50%
€1.35
Target price
27.10.26
€6.02
Performance (%)
-37.47%
Price
09:34
€0.84
Summary
This prediction is currently active. Massive losses of -37.47% have been the result for the BUY prediction by Wedbush. This prediction currently runs until 27.10.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | -6.204% | -6.204% |
| iShares Core DAX® | 1.330% | -1.723% |
| iShares Nasdaq 100 | 1.099% | -2.569% |
| iShares Nikkei 225® | 1.265% | -6.613% |
| iShares S&P 500 | 1.000% | -0.871% |
Comments by Wedbush for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock, up previously from $5.00.
Ratings data for FATE provided by MarketBeat